Antibody production market to reach USD $53.78 billion by 2030 at 15.7% CAGR, driven by automation adoption and therapeutic antibody demand.
Read MoreGlobal Antibody Contract Manufacturing market size is expected to reach $34.72 billion by 2030 at 15.8%, surge in clinical trials fuels the antibody contract manufacturing market growth
Read MoreThe Antibodies market size is expected to reach $666.72 billion in 2030 at a CAGR of 15.0%, driven by precision immunotherapies
Read MoreGlobal Antibiotic Resistance market size is expected to reach $18.22 billion by 2030 at 7.3%, the impact of rising drug-resistant infections on the antibiotic resistance market
Read MoreThe Anti-Acne Dermal Patch market is projected to reach $1.76 billion by 2030, growing at a 9.5% CAGR driven by clean-label skincare demand
Read MoreAnti hemagglutinin (ha) antibody market to reach USD $2.7 billion by 2030 at 10.2% CAGR, driven by diagnostic assay applications and biotech advances.
Read MoreGlobal Anterior Uveitis market size is expected to reach $0.98 billion by 2030 at 11.2%, impact of autoimmune disease surge on inflammatory eye conditions
Read MoreGlobal Anosmia market size is expected to reach $6.07 billion by 2030 at 9.5%, segmented as by idiopathic anosmia, partial idiopathic anosmia, complete idiopathic anosmia
Read MoreGlobal Anorectal Disorders Treatment market size is expected to reach $6.22 billion by 2030 at 7.1%, segmented as by drugs, topical agents, oral medications, rectal suppositories
Read MoreGlobal Ankylosing Spondylitis market size is expected to reach $9.42 billion by 2030 at 8.3%, ankylosing spondylitis market surges with the growing geriatric population worldwide
Read More